Summary:
Study evaluating the ability of new therapy to reduce number of seizures in epileptic patients.
Qualified participants will receive all Study-related care and Study medication at no cost
and may be compensated for time and travel.
Qualified Participants Must:
• be between 18 and 75 years of age
• be diagnosed with epilepsy for at least two years
• be still having seizures while on epilepsy medication
• experience 8 or more seizures per two months even while on medication
Qualified Participants May Receive:
Compensation offered for time and travel.